Covaxin effectively neutralises Delta and Alpha variants of coronavirus: Top US health institute



The National Institute of Health (NIH) in the United States has found that Bharat Biotech’s COVAXIN vaccine generates antibodies that effectively neutralize both Alpha and Delta variants of COVID-19. The top health research institute said that an adjuvant developed with funding from the NIH has contributed to the success of the “highly efficacious” COVAXIN COVID-19 vaccine, which roughly 25 million people have received to date in India and elsewhere.

► Subscribe to The Economic Times for latest video updates. It’s free! – http://www.youtube.com/TheEconomicTimes?sub_confirmation=1

► More Videos @ ETTV – http://economictimes.indiatimes.com/TV

http://EconomicTimes.com

► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp

Follow ET on:

► Facebook – https://www.facebook.com/EconomicTimes
► Twitter – http://www.twitter.com/economictimes
► LinkedIn – http://www.linkedin.com/company/economictimes
► Instagram – https://www.instagram.com/the_economic_times
► Flipboard – https://flipboard.com/@economictimes

source